Institutional investors hold a majority ownership of LLY through the 65.59% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2016, these large investors purchased a net $2.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 11.7 Million shares of Eli Lilly and Co
UBS ASSET MANAGEMENT (AMERICAS) ... Bought 4.9 Million shares of Eli Lilly and Co
FRANKLIN MUTUAL ADVISERS LLC Bought 2.7 Million shares of Eli Lilly and Co